Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Affiliated Hospital of Qingdao University32 Tianjin Medical University17 Qilu Hospital of Shandong University8 Qingdao Central Hospital6 Alexion Pharmaceuticals, Inc.3
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Qingdao

171 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Chunshui He
Observational
600
Beijing, Xiamen, Hangzhou, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu
2027-01-01
Not yet open
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
Multi-center Prospective Validation of Real-Time AI-EGGIM System
NCT07915843Gastric Intestinal Metaplasia
Qilu Hospital of Shandong University
Observational
540
Binzhou, Jinan, Qingdao
2026-11-01
Not yet open
Ruijin Hospital
Not applicable
56
Qingdao, Shanghai, Xi’an, Chengdu
2026-10-28
Not yet open
Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
NCT07902596Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Observational
2,000
Shijiazhuang, Lianyungang, Nanjing, Suzhou, Qingdao, Shanghai
2026-10-25
Not yet open
Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast
NCT07657169Radiotherapy, Adjuvant, Phyllodes Breast Tumor, Prognosis, Molecular Typing
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
160
Guangzhou, Shenzhen, Jinan, Qingdao
2026-10-15
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
150
Qingdao
2026-10-02
Recruiting
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
NCT07813559Thrombi, Thrombus, Brain, Thrombus
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2026-09-01
Not yet open
Zhejiang Cancer Hospital
Phase 3
140
Guangzhou, Jiangmen, Wuhan, Changsha, Ganzhou, Jinan, Qingdao, Chengdu
2026-09
Not yet open
The Affiliated Hospital of Qingdao University
Observational
200
Qingdao
2026-08-20
Recruiting
Xijing Hospital
Observational
5,000
Xi'an, Dalian, Hami, Heze, Jinan, Langfang, Liu‘an, Qingdao
2026-08-10
Recruiting
Peking University Third Hospital
Not applicable
192
Beijing, Qingdao, Shanghai, Wuhan
2026-08-10
Not yet open
Prophylactic IABP in Delayed-Presentation Anterior STEMI
NCT07761455Acute Anterior ST-Segment Elevation Myocardial Infarction
Qilu Hospital of Shandong University
Not applicable
504
Jinan, Jining, Qingdao, Beijing
2026-08-01
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
328
Qingdao
2026-08-01
Not yet open
Multimodal Prehabilitation for Tumor-Related Bowel Obstruction
NCT07767760Malignant Tumor, Prehabilitation
The Affiliated Hospital of Qingdao University
Not applicable
394
Qingdao
2026-08-01
Not yet open
Shanghai Zhongshan Hospital
Observational
400
Guangzhou, Nanning, Harbin, Qingdao, Shanghai, Kunming
2026-07-31
Recruiting
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
NCT07714980Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
300
Dongying, Qingdao, Rizhao, Weifang, Weihai, Yantai
2026-07-25
Not yet open
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT07676266Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2026-07
Not yet open
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2026-07
Recruiting
Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
NCT07685860Depression, Anxiety, Heart Injuries
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
NCT07685873Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2026-06-25
Recruiting
Hoffmann-La Roche
Phase 3
380
Guangzhou, Nanjing, Qingdao, Tianjin, Kunming, Hangzhou, Jinan, Nanning
2026-06-23
By invitation
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xi’an
2026-06-18
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
76
Beijing, Guangzhou, Qingdao, Shanghai
2026-06-01
Recruiting
Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
NCT07618936PD-L1 Gene Mutation, PD-L1 Gene Amplification, PD-L1-related Disease, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2026-06-01
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
144
Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao
2026-05-31
Recruiting
The Affiliated Hospital of Qingdao University
Phase 4
294
Qingdao, Weifang
2026-05-22
Not yet open
The Affiliated Hospital of Qingdao University
Phase 4
20
Qingdao, Weihai, Yantai, Zibo
2026-05-01
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
180
Qingdao
2026-04-24
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
32
Qingdao
2026-04-22
Recruiting
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Shijiazhuang, Jinan, Qingdao, Taiyuan, Tianjin
2026-04-13
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Not yet open
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
NCT07481903Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not applicable
228
Beijing, Nanjing, Qingdao, Tianjin
2026-04
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
24
Xiamen, Zhengzhou, Qingdao
2026-04
Recruiting
Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG
NCT07302659Coronary Artery Bypass Graft (CABG)
China National Center for Cardiovascular Diseases
Not applicable
380
Beijing, Qingdao, Shenzhen
2026-03-10
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
18
Guangzhou, Qingdao, Tai’an, Chongqing
2026-03-05
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Recruiting
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-03-02
Not yet open
The Affiliated Hospital of Qingdao University
Phase 1/2
9
Guangzhou, Qingdao, Tai’an, Chongqing
2026-02-28
Not yet open
Haitao Niu, MD
Phase 2
27
Qingdao
2026-02-27
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Not yet open
Preventing Neurologic Complications in Valve Surgery
NCT07382362Left Atrial Appendage Closure
China National Center for Cardiovascular Diseases
Observational
100
Beijing, Qingdao, Shenzhen
2026-01-27
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Active, closed
The Affiliated Hospital of Qingdao University
Phase 1
28
Qingdao
2026-01-22
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases
Beijing Tsinghua Chang Gung Hospital
Observational
1,800
Beijing, Chongqing, Qingdao, Shandong, Zhuhai
2026-01-14
Recruiting
Effect of Predictive Model on Double-Balloon Enteroscopy
NCT07288346Double-balloon Enteroscopy
Shandong University
Not applicable
338
Dezhou, Qingdao, Yantai, Zaozhuang, Jinan
2026-01-12
Recruiting
Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer
NCT07708012Early-stage Upper Gastrointestinal Cancer, Stomach Cancer, Adenocarcinoma, Laparoscopy-assisted Surgery, Endoscope
wangdongsheng
Not applicable
9
Qingdao
2026-01-08
Not yet open
Tongji Hospital
Phase 2
78
Fuzhou, Nanning, Taihe, Wuhan, Jinan, Qingdao
2025-12-31
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
DrugIparomlimab and Tuvonralimab
Peking University
Phase 2
106
Shijiazhuang, Harbin, Zhengzhou, Nanjing, Xi'an, Qingdao, Taiyuan, Chengdu
2025-12-15
Recruiting
Central China Fuwai Hospital of Zhengzhou University
Not applicable
738
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Qingdao
2025-12-01
Recruiting
Eli Lilly and Company
Phase 2
252
Changzhou, Chongqing, Fuzhou, Hangzhou, Kunming, Nanjing, Qingdao, Shenyang
2025-11-10
Recruiting
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598Neurodegenerative Disease, Alzheimer s Disease, Tauopathies
Tianjin Medical University
Observational
20
Hefei, Qingdao, Tianjin
2025-11-01
Not yet open
The Affiliated Hospital of Qingdao University
Phase 4
238
Qingdao
2025-10-31
Recruiting
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
NCT07648693Transcatheter Aortic Valve Replacement (TAVR), Cerebral Vascular Accident (CVA)/Stroke
Resonova (Shanghai) Medtech Limited
Not applicable
240
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanchang, Qingdao
2025-10-31
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
90
Qingdao
2025-09-20
Recruiting
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy
NCT07125586Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
The Affiliated Hospital of Qingdao University
Not applicable
353
Qingdao
2025-08-26
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
300
Qingdao
2025-08-01
Not yet open
China-Japan Friendship Hospital
Observational
100,000
Beijing, Shanghai, Changsha, Guiyang, Hangzhou, Henan, Qingdao, Shenyang
2025-08-01
Recruiting
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
NCT07130409Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), PET / MR
The Affiliated Hospital of Qingdao University
Observational
20
Qingdao
2025-08
Recruiting
The Affiliated Hospital of Qingdao University
Observational
60
Qingdao
2025-07-30
Recruiting
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT07232459Amyloid, Cardiac Amyloidosis, Amyloidosis, Healthy Subjects
Tianjin Medical University
Observational
25
Hefei, Qingdao, Tianjin
2025-07-21
Recruiting
BeOne Medicines
Phase 1
58
Beijing, Chongqing, Guangzhou, Wuhan, Changsha, Qingdao, Chengdu, Hangzhou
2025-07-19
Recruiting
Daiichi Sankyo
Phase 2
130
Beijing, Changchun, Guangzhou, Hangzhou, Nanchang, Nanjing, Nanning, Qingdao
2025-07-18
Recruiting
AstraZeneca
Phase 2
100
Beijing, Changchun, Changzhi, Chengdu, Fuzhou, Hangzhou, Kunming, Qingdao
2025-07-17
Active, closed
Qingdao Central Hospital
Phase 2
49
Qingdao
2025-07-01
Recruiting
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-07-01
Recruiting
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
240
Chongqing, Shenzhen, Haikou, Hohhot, Shenyang, Qingdao, Tacheng
2025-07-01
Not yet open
Pharmacokinetics and Pharmacodynamics Study
NCT07074236Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd.
Phase 1
48
Qingdao
2025-07
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
37
Fuzhou, Shijiazhuang, Changsha, Jinan, Qingdao, Tianjin
2025-07
Recruiting
wanghaibo
Phase 2
120
Dalian, Qingdao
2025-06-25
Not yet open
Chinese University Students' Death Attitudes and Their Initial Sandplay Characteristics
NCT07020143Death Attitude (Implicit/Explicit), Sandplay Therapy
Kai Huang
Observational
100
Qingdao
2025-06-20
Recruiting
Second Affiliated Hospital of Guangxi Medical University
Observational
10,000
Beihai, Guilin, Nanning, Qingdao
2025-06-19
Active, closed
Zichao Zhang
Not applicable
64
Qingdao
2025-06-03
Recruiting
The Affiliated Hospital of Qingdao University
Phase 2
35
Qingdao
2025-06-01
Recruiting
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117Heart Valve Disease, Mitral Valve (MV) Regurgitation, Mitral Valve Disease, Mitral Valve Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Fuzhou, Wuhan, Changsha, Shenyang, Xi'an, Qingdao, Chengdu, Ürümqi
2025-06-01
Not yet open
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial
Peking University People's Hospital
Not applicable
1,389
Beijing, Chongqing, Handan, Harbin, Wuhan, Changchun, Jinan, Qingdao
2025-06
Recruiting
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2025-05-16
Recruiting
The Affiliated Hospital of Qingdao University
Observational
300
Qingdao
2025-05-14
Active, closed
Carina™ Surgical Platform for Minimal Radical Gastrectomy
NCT07113340Robotic Gastrectomy, Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
20
Qingdao
2025-05-01
Recruiting
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
144
Qingdao
2025-04-16
Recruiting
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
NCT06916624Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)
The Affiliated Hospital of Qingdao University
Observational
120
Qingdao
2025-04-12
Recruiting
The Affiliated Hospital of Qingdao University
Observational
30
Qingdao
2025-04-11
Recruiting
The Affiliated Hospital of Qingdao University
Observational
40
Qingdao
2025-04-09
Recruiting
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
Alpha-Synuclein PET/CT in Various α-Syn-Related Disease
NCT06949670Alpha Synuclein Pathology, Alpha-Synuclein, Parkinson Disease
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2025-04-01
Recruiting
The Hong Kong Polytechnic University
Not applicable
256
Qingdao
2025-04-01
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Not yet open
The Affiliated Hospital of Qingdao University
Phase 1
32
Qingdao
2025-01-02
Recruiting
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
NCT07322783EGFR Positive Non-small Cell Lung Cancer, MET Amplification
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-01-01
Recruiting
The Affiliated Hospital of Qingdao University
Phase 1
120
Qingdao
2024-12-04
Active, closed
AbbVie
Observational
110
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Dalian, Xi'an, Qingdao
2024-11-13
Recruiting
Digital Early Warning System for Acute Lung Injury in Liver Surgery
NCT07070362Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD
Beijing Tsinghua Chang Gung Hospital
Observational
3,000
Beijing, Chongqing, Qingdao
2024-11-01
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
NCT06730373HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma
DrugsTeysuno·Disitamab Vedotin·Trastuzumab·Adrucil
Qilu Hospital of Shandong University
Phase 2
110
Zhengzhou, Binzhou, Dongying, Jinan, Jining, Liaocheng, Linyi, Qingdao
2024-10-17
Recruiting
TEAS for Gastrectomy Recovery
NCT07898293Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
104
Qingdao, Rizhao, Weifang, Yantai
2024-10-07
Recruiting
Qilu Hospital of Shandong University
Observational
293
Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian
2024-10-01
Active, closed
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xi’an
2024-09-03
Active, closed
MRI Assessment of Pancreatic Fat Changes and Islet Function Recovery After Bariatric Surgery in Obese Patients
NCT07464223Obesity & Overweight, Type 2 Diabetes Mellitus (T2DM), Pancreatic Steatosis, Insulin Resistance
yu li，MD
Observational
50
Qingdao
2024-09-01
Recruiting
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Recruiting
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
216
Beijing, Changchun, Guangzhou, Hangzhou, Jinan, Nanning, Nantong, Qingdao
2024-07-30
Not yet open
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
702
Wuhan, Qingdao
2024-07-01
Active, closed
Hoffmann-La Roche
Phase 3
68
Beijing, Chengdu, Guangzhou, Harbin, Qingdao, Shanghai, Shenyang, Taiyuan
2024-06-17
Recruiting
Nutrition Impact on Immunotherapy of Cancer
NCT06500234Nutrition Disorders, Immunotherapy, Cancer, Survival, Prosthesis
Qingdao Central Hospital
Phase 3
300
Qingdao
2024-06-01
Active, closed
The Affiliated Hospital of Qingdao University
Observational
500
Qingdao
2024-06-01
Active, closed
Ton-Bridge Medical Tech. Co., Ltd
Not applicable
188
Shenyang, Linyi, Qingdao, Jinan, Lishui, Beijing
2024-04-24
Active, closed
Evolve China PMCF Study
NCT06368622Intracranial Aneurysm
Stryker Neurovascular
Observational
500
Beijing, Changchun, Fuzhou, Guangzhou, Kunming, Nanyang, Ningbo, Qingdao
2024-04-24
Recruiting
Qingdao Central Hospital
Observational
70
Qingdao
2024-04-17
Recruiting
Shandong University
Phase 2
83
Changsha, Nanjing, Jinan, Qingdao, Taiyuan, Hangzhou
2024-04-15
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
152
Beijing, Guangzhou, Haerbin, Zhengzhou, Wuhan, Changsha, Jinan, Qingdao
2024-01-23
Active, closed
AbbVie
Phase 4
120
Beijing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Wuhan, Qingdao, Chengdu
2024-01-09
Recruiting
Jin Lu, MD
Not applicable
41
Beijing, Nanjing, Qingdao, Xi’an
2024-01-05
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Beijing, Changsha, Chengdu, Nanchang, Qingdao, Shanghai, Shenzhen
2024-01-03
Active, closed
Qilu Hospital of Shandong University
Observational
197
Jinan, Qingdao, Yantai
2024-01-01
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Beijing, Guangzhou, Zhengzhou, Suzhou, Nanchang, Shenyang, Qingdao, Shanghai
2023-12-29
Recruiting
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
NCT07130565Amyloid, Cardiac Amyloidosis, Amyloidosis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2023-11-01
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Xiamen, Guangzhou, Zhengzhou, Wuhan, Yancheng, Shenyang, Qingdao, Shanghai
2023-10-23
Active, closed
Qilu Hospital of Shandong University
Not applicable
65
Jinan, Qingdao, Yantai
2023-10-01
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT06035250Gastric Cancer, Image, Pathology
Chinese Academy of Sciences
Observational
200
Beijing, Changsha, Fuzhou, Guangzhou, Kunming, Nanning, Qingdao, Shanghai
2023-09-10
Recruiting
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
NCT06544720Human Papillomavirus Associated Carcinomas, Cervical Cancer, Head and Neck Cancers, Anal Cancer
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2023-08-02
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
588
Qingdao
2023-07-07
Recruiting
China-Japan Friendship Hospital
Phase 4
336
Beijing, Baoding, Qinhuangdao, Gongyi, Yangzhou, Jining, Qingdao, Changzhi
2023-03-29
Recruiting
A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors
NCT05718895Advanced/Metastatic Solid Tumors
DrugATG-022
Antengene Biologics Limited
Phase 1
156
Beijing, Chengdu, Fuzhou, Hefei, Jinan, Lanzhou, Qingdao, Shanghai
2023-03-27
Active, closed
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
NCT06047964Stroke, Intracranial Atherosclerotic Stenosis
B. Braun Medical International Trading Company Ltd.
Not applicable
281
Beijing, Harbin, Nanyang, Changchun, Jining, Qingdao, Shanghai, Taiyuan
2023-03-23
Active, closed
Qilu Hospital of Shandong University
Phase 2
59
Jinan, Qingdao, Yantai, Linyi
2023-03-01
Active, closed
Qilu Hospital of Shandong University
Phase 2
55
Jinan, Qingdao, Yantai
2023-02-10
Not yet open
Qingdao Central Hospital
Phase 3
6,792
Qingdao
2022-12-06
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Hangzhou, Jinan, Qingdao
2022-11-21
Recruiting
The Affiliated Hospital of Qingdao University
Phase 3
616
Qingdao
2022-11-20
By invitation
Peking University International Hospital
Phase 4
102
Beijing, Qingdao, Shanghai, Xi’an
2022-11-01
Recruiting
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
NCT05578300Ischemic Stroke, Stroke, Stroke, Acute, Stroke, Ischemic
Chinese University of Hong Kong
Observational
350
Linyi, Qingdao
2022-10-21
Not yet open
The Affiliated Hospital of Qingdao University
Early Phase 1
10
Qingdao
2022-10-08
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
40
Beijing, Haerbin, Qingdao
2022-09-26
Active, closed
The Affiliated Hospital of Qingdao University
Not applicable
368
Qingdao
2022-09-01
Recruiting
Zhejiang Provincial People's Hospital
Phase 2
80
Qingdao, Hangzhou, Ningbo, Tianjin, Wenzhou
2022-09-01
Active, closed
GlaxoSmithKline
Phase 3
163
Beijing, Guangzhou, Hefei, Nanjing, Qingdao, Shanghai, Shenzhen, Wenzhou
2022-07-14
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Beijing, Chengdu, Haikou, Hengyang, Kunming, Nanchang, Qingdao, Wenzhou
2022-06-30
Active, closed
Sanofi
Phase 3
531
Beijing, Changsha, Guangzhou, Hangzhou, Nanchang, Nanning, Qingdao, Shenyang
2022-06-23
Recruiting
A Prognostic Model for Drug-induced Liver Injury in China
NCT05060289Drug-induced Liver Injury
Beijing Friendship Hospital
Observational
3,000
Beijing, Dalian, Guangxi, Hebei, Jiaozuo, Lanzhou, Qingdao, Qinghai
2022-05-25
Recruiting
Actelion
Phase 3
280
Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
2022-05-04
Active, closed
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
NCT05352074Slow Transit Constipation, Surgery
Third Military Medical University
Not applicable
252
Yuzhong, Lanzhou, Wuhan, Nanjing, Shengyang, Qingdao, Pudong, Xi’an
2022-03-27
Recruiting
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071FAP-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2022-03-01
Recruiting
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NCT06690736CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Not applicable
200
Hefei, Qingdao, Tianjin
2022-03-01
Active, closed
Takeda
Observational
72
Hefei, Beijing, Zhengzhou, Hohhot, Suzhou, Nanchang, Shenyang, Qingdao
2021-10-29
Active, closed
AstraZeneca
Phase 3
927
Beijing, Changsha, Chongqing, Guangzhou, Kunming, Nanning, Qingdao, Shanghai
2021-10-25
Active, closed
Sanofi
Phase 3
17
Qingdao, Shanghai
2021-09-01
Active, closed
Shandong University
Phase 2
106
Jinan, Qingdao
2021-08-21
Active, closed
Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament
NCT04968028Ossification of Posterior Longitudinal Ligament, Cervical Spondylosis With Myelopathy
Shanghai Changzheng Hospital
Not applicable
167
Beijing, Shenzhen, Harbin, Jining, Qingdao, Shanghai, Taiyuan, Xi’an
2021-08-17
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Observational
496
Nanjing, Qingdao
2021-07-10
Recruiting
Boston Scientific Corporation
Observational
5,000
Chaoyang, Xicheng, Chongqing, Guangzhou, Qingdao, Huangpu, Yangpu, Taiyuan
2021-03-29
Active, closed
Celgene
Phase 3
313
Guangzhou, Nanyang, Changsha, Nanjing, Nantong, Nanchang, Qingdao, Taiyuan
2021-02-25
Active, closed
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
NCT04826705Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
2,000
Wuhan, Beijing, Chengdu, Hangzhou, Qingdao, Shanghai, Suzhou
2021-02-01
Active, closed
Amgen
Phase 1/2
181
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Qingdao, Xi’an
2021-01-04
Recruiting
Nanjing Medical University
Not applicable
300
Guangzhou, Nanjing, Qingdao, Chengdu, Beijing
2021-01-01
Recruiting
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
NCT05620095Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Beijing, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu, Hangzhou
2020-12-01
Recruiting
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
NCT06690970PSMA-related Disease, Prostate Cancer, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2020-09-01
Recruiting
Ruijin Hospital
Observational
1,000
Beijing, Hanzhong, Cangzhou, Shijiazhuang, Qingdao, Shanghai, Shenyang
2020-07-30
Active, closed
BioRay Pharmaceutical Co., Ltd.
Phase 3
408
Qingdao
2020-06-28
Active, closed
Actelion
Phase 3
138
Beijing, Guangzhou, Qingdao, Shanghai, Shenyang
2020-01-16
Recruiting
Alexion Pharmaceuticals, Inc.
Observational
500
Chengdu, Beijing, Changchun, Guangzhou, Jinan, Nanchang, Qingdao, Shijiazhuang
2019-12-02
Active, closed
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease
Ruijin Hospital
Not applicable
792
Hefei, Fuzhou, Zhengzhou, Changsha, Jinan, Qingdao, Shanghai, Tianjin
2019-08-04
Recruiting
National Research Institute for Family Planning, China
Observational
20,000
Zhongshan, Zhangjiakou, Daqing, Changzhou, Yangzhou, Hohhot, Qingdao, Zaozhuang
2019-06-01
Recruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693GLP1-R-related Disease, Tumor, Insulinoma, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
Translocator Protein PET/CT in Various TSPO-Related Disease
NCT06725719Neuroinflammation, Stroke, Neurodegenerative Diseases
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2018-11-01
Recruiting
Tau PET/CT in Various Tau-Related Disease Patients
NCT06690983Tauopathies, Neurodegenerative Diseases, Neurodegeneration
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2018-08-01
Active, closed
Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery
NCT03012971Elderly, Surgery, Analgesia, Dexmedetomidine
Peking University First Hospital
Not applicable
1,500
Beijing, Chongqing, Guiyang, Baoding, Changsha, Xi'an, Qingdao, Taiyuan
2017-01-06
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 2/3
300
Qingdao, Shanghai
2015-01
Recruiting
Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases
NCT07379463Amino-Acid Transport Disorder, Primary Hyperparathyroidism, Glioma
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2013-08-29
Recruiting
Beta Amyloid PET/CT in Various Aβ-Related Disease
NCT06725706Amyloid, Beta-Amyloid, Neurodegenerative Diseases
Tianjin Medical University
Observational
500
Hefei, Beijing, Qingdao, Tianjin
2012-09-01
Rows per page Showing 1–171 of 171
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 171 of those studies with a site in Qingdao.

How many clinical trials are recruiting in Qingdao?

91 of the 171 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 38 have not yet opened recruitment, 40 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 171 studies
PhaseStudiesRecruitingShare
Observational594134.5%
Not applicable381622.2%
Phase 2221312.9%
Phase 320511.7%
Phase 11689.4%
Phase 4724.1%
Phase 1/2643.5%
Phase 2/3221.2%
Early Phase 1100.6%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
The Affiliated Hospital of Qingdao University3217
Tianjin Medical University1717
Qilu Hospital of Shandong University82
Qingdao Central Hospital64
Alexion Pharmaceuticals, Inc.31
Jiangsu Hansoh Pharmaceutical Co., Ltd.32
Ruijin Hospital31
Shandong University32
AbbVie20
Actelion21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.